top of page


AbbVie and Iambic enter AI-driven drug discovery collaboration across immunology, neuroscience and oncology
AbbVie and Iambic have entered a multi-year collaboration to use artificial intelligence and computational drug discovery across immunology, neuroscience and oncology.

nuaxia
Sep 222 min read


Biocytogen licenses fully human VHH antibody to Qilu Pharmaceutical for neuroscience development
Biocytogen has granted Qilu Pharmaceutical non-exclusive rights to a fully human VHH antibody from its RenNano platform for the development of neuroscience therapies.

nuaxia
Sep 32 min read
bottom of page